Skip to main content
Premium Trial:

Request an Annual Quote

SummerBio Raises $7.3M, Implements SARS-CoV-2 Molecular Testing at Los Angeles Schools

NEW YORK ─ SummerBio on Wednesday announced it has raised $7.3 million in an equity financing round and is conducting testing for the University of California Los Angeles (UCLA) and the Los Angeles Unified School District that leverages its RT-PCR SARS-CoV-2 test.

Investors in the equity financing round included Intel Capital, Capricorn Investment Group, 8VC, Toyota AI Ventures, Joby Trust, Dayton Family Enterprises, and Sciarra Management Trust.

The firm said that its RT-PCR test is conducted in a CLIA-certified laboratory and administered by a healthcare professional using a nasal swab, leading to results within 24 hours of collection.

The test is based on an RT-PCR assay developed by a team at New York-based Columbia University. It leverages robotics and automated high-throughput liquid handling systems to reduce process inefficiencies and supply bottlenecks, SummerBio said.

The Menlo Park, California-based firm added that it plans to increase testing capacity for its COVID-19 laboratory to about 100,000 tests per day by the end of this year and offer testing at a cost of less than $20 per test.

The firm also said that Srini Ananth, investment director at Intel Capital, and Ajit Singh, partner at Artiman Ventures, joined SummerBio's board.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.